Ardelyx to Present New Data on Hyperphosphatemia Management at ASN Kidney Week 2026

ConferenceXPHOZAHPositive

AI Analysis

Summary

Ardelyx will present real-world data on XPHOZAH (tenapanor) for hyperphosphatemia management at ASN Kidney Week 2026. The presentation will include new insights into hyperphosphatemia management and outcomes.

Importance:3/10

Sentiment:

0.30

real-world datahyperphosphatemiaASN Kidney Weekconference presentation

Related Companies

$ARDX

Read the original article

Published by GlobeNewswire Clinical Studies on October 5, 2026 12:01 PM

Read Original